Back to search
Vulvovaginal Atrophy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Vulvovaginal Atrophy trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Vulvovaginal Atrophy trials you may qualify forBreast cancer survivors (BCS) often face unique challenges during and after treatment, including the onset of menopause-related symptoms. Genitourinary Syndrome…
The goal of this clinical trial is to improve the management of Genitourinary syndrome of menopause (GSM) to preliminary assess safety and effectivity of a nove…
This Phase III, randomized, balanced, parallel-group, multicenter trial aims to evaluate the effect of vaginal radiofrequency on symptoms of vaginal dryness at…
Vulvo Vaginal Atrophy (VVA) refers to the changes in the vaginal and vulvar surfaces that occurs during menopause due to the progressive loss of estrogen. The l…
This is a randomized, controlled trial aiming to evaluate the effectiveness of adding vaginal dilators to the treatment of vulvovaginal atrophy. Study Populati…
This study is a prospective, randomized controlled, phase II clinical study with a planned enrolment of 60 patients. The study focuses on the efficacy and safet…
The primary aim of this study is to evaluate the feasibility of testing a multi-component intervention for sexual function using a factorial design.
In this prospective active-controlled randomized trial the investigators will assess for the first time ever the different local treatments of vulvovaginal atro…